Tuesday, August 2, 2016

Vol. 22, No. 15

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 22, No. 15  August 1, 2016
(The next issue will be on August 15, 2016)
_________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
_________________________________
PAPERS IN PRESS
None Submitted for this issue.
_________________________________
UPCOMING MEETINGS EVENTS
The annual meeting of the American Society of Hematology (ASH) will be held in San Diego, CA, USA, from December 3-6, 2016. The abstract deadline is August 4, 2016. For more information:

    * * *   * * *   * * *
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm

ISTH also maintains a list of upcoming meetings of interest:
_________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":

Amano K, Seita I, Higasa S, Sawada A, Kuwahara M, Shima M (2016) Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data. Haemophilia.

Ansell JE, Laulicht BE, Bakhru SH, Hoffman M, Steiner SS, Costin JC
(2016) Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin. Thromb Res.

Bang OY, Chung JW, Lee MJ, Kim SJ, Cho YH, Kim GM, . . . Moon GJ
(2016) Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent
Way: The OASIS-CANCER Study. PLoS One 11:e0159170.

Behera SS, Pramanik K, Nayak MK (2015) Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology. Curr Pharm Des 21:4479-4497.

Behling-Kelly E, Rivera-Rivas J, Czuprynski CJ (2016) Interactions of Histophilus somni with Host Cells. Curr Top Microbiol Immunol 396:71-87.

Bhattacharjee J, Das B, Sharma D, Sahay P, Jain K, Mishra A, . . .
Upadhyay P (2016) Autologous NeoHep Derived From Chronic Hepatitis B Virus Patients' Blood Monocytes by Upregulation of cMET Signaling.
Stem Cells Transl Med.

Courtney JM, Ye Q, Nesbitt AE, Tang M, Tuttle MD, Watt ED, . . .
Rienstra CM (2015) Experimental Protein Structure Verification by Scoring with a Single, Unassigned NMR Spectrum. Structure 23:1958-1966.

Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J, Zuchtriegel G, Krombach F, . . . Kanse SM (2016) Factor VII activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation. J Thromb Haemost.

Durila M, Pavlicek P, Hadacova I, Nahlovsky J, Janeckova D (2016) Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report. Medicine (Baltimore) 95:e2933.

Eden D, Siegbahn A, Mokhtari D (2015) Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.
Diabetologia 58:2563-2572.

Enjeti AK, Ariyarajah A, D'Crus A, Seldon M, Lincz LF (2016) Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects. Thromb Res 145:18-23.

Ezzelarab MB, Cooper DK (2015) Systemic inflammation in xenograft recipients (SIXR): A new paradigm in pig-to-primate xenotransplantation? Int J Surg 23:301-305.

Franklin SW, Szlam F, Fernandez JD, Leong T, Tanaka KA, Guzzetta NA
(2016) Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
Anesth Analg 122:935-942.

Gamperl H, Plattfaut C, Freund A, Quecke T, Theophil F, Gieseler F
(2016) Extracellular vesicles from malignant effusions induce tumor cell migration: Inhibitory effect of LMWH tinzaparin. Cell Biol Int.

Gissel M, Brummel-Ziedins KE, Butenas S, Pusateri AE, Mann KG, Orfeo T (2016) Effects of an acidic environment on coagulation dynamics. J Thromb Haemost.

Gleeson BM, Martin K, Ali MT, Kumar AH, Pillai MG, Kumar SP, . . .
Caplice NM (2015) Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. Stem Cells 33:2726-2737.

Gong X, Duan R, Ao JE, Ai Q, Ge P, Lin L, Zhang L (2015) Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/Dgalactosamineinduced fulminant hepatitis. Mol Med Rep 12:6384-6390.

Hansson KM, Johansson KJ, Wingren C, Fries D, Nelander K, Lovgren A
(2016) Recombinant human prothrombin reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding. Blood Coagul Fibrinolysis.

Herklotz M, Hanke J, Hansel S, Drichel J, Marx M, Maitz MF, Werner C
(2016) Biomaterials trigger endothelial cell activation when co-incubated with human whole blood. Biomaterials 104:258-268.

Kessler CM, Ma AD, Al-Mondhiry HA, Gut RZ, Cooper DL (2016) Assessment of acquired hemophilia patient demographics in the United
States: the Hemostasis and Thrombosis Research Society Registry.
Blood Coagul Fibrinolysis.

Kumar R, Sedky MJ, Varghese SJ, Sharawy OE (2016) Transfusion Related Acute Lung Injury (TRALI): A Single Institution Experience of 15 Years. Indian J Hematol Blood Transfus 32:320-327.

Lakbakbi S, Debrumetz A, Rieu P, Nguyen P (2015) Human Neutrophils Support Thrombin Generation in Peritonitis. Perit Dial Int 35:599-602.

Lakbakbi S, Debrumetz A, Terryn C, Szymezak J, Rieu P, Nguyen P
(2016) Tissue factor expressed by adherent cells contributes to hemodialysis-membrane thrombogenicity. Thromb Res 144:218-223.

Lasala J, Patino MA, Mena G, Vachhani S, Moon T, Bui T, Tsai J (2016) Severe perioperative bleeding in renal cell carcinoma after elective pericardiocentesis associated left ventricular puncture: case report.
Medwave 16:e6494.

Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM (2016) Transforming growth factor-beta (TGF-beta) inhibits the expression of factor VII activating protease (FSAP) in hepatocytes. J Biol Chem.

Lentz SR, Rangarajan S, Karim FA, Andersen PD, Arkhammar P, Rosu G, Mahlangu J (2016) The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial. Blood Coagul Fibrinolysis.

Liu RZ, Zhang J, Liu T, Fu XY, Zhang LM, Xie MQ (2016) [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro]. Zhonghua Yi Xue Za Zhi 96:2023-2030.

Martinez-Moreno JM, Herencia C, Montes de Oca A, Munoz-Castaneda JR, Rodriguez-Ortiz ME, Diaz-Tocados JM, . . . Almaden Y (2016) Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells. FASEB J 30:1367-1376.

Muhsin-Sharafaldine MR, Saunderson SC, Dunn AC, Faed JM, Kleffmann T, McLellan AD (2016) Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget.

Nakase H, Motoyama Y, Yamada S (2016) [Cerebral hemorrhage]. Nihon Rinsho 74:671-676.

Peng Z, Andersson K, Lindholm J, Dethlefsen O, Pramana S, Pawitan Y, . . . Li C (2016) Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material. PLoS One 11:e0145545.

Ruff CT, Giugliano RP, Antman EM (2016) Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents. Circulation 134:248-261.

Shahbazi S, Khorasani M, Mahdian R (2016) Gene expression profile of FVII and AR in primary prostate cancer. Cancer Biomark.

Slomka A, Switonska M, Zekanowska E, Sinkiewicz W (2016) ANNALS
EXPRESS: Hemostatic factors do not account for worse outcomes from ischemic stroke in patients with higher C-reactive protein levels.
Ann Clin Biochem.

Toby GG, Liu T, Buyue Y, Zhang X, Bitonti AJ, Pierce GF, . . . Peters RT (2016) Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice. PLoS One 11:e0148255.

Xia L, Xie H, Yu Y, Zhou H, Wang T, Yan J (2016) The Effects of NF-kappaB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-beta2GPI in Mouse. PLoS One 11:e0147958.

Zhang X, Glunz PW, Johnson JA, Jiang W, Jacutin-Porte S, Ladziata V, . . . Priestley ES (2016) Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex. J Med Chem.

_________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
_________________________________